Therapeutic drug monitoring

Keyphrases

Publications

volume 46, number 2, 2024

Georgios Schoretsanitis, null null
Establishing and Extending the Use of Therapeutic Drug Monitoring in Neuropsychopharmacology. Therapeutic drug monitoring 46 (2) (2024)
Maxim Kuzin, Ekkehard Haen, Nazar Kuzo, Katharina Endres, Christoph Hiemke, Michael Paulzen, Georgios Schoretsanitis
Assessing Pharmacokinetic Correlates of Escitalopram-Related Adverse Drug Reactions. Therapeutic drug monitoring 46 (2) (2024)
Maxim Kuzin, Ekkehard Haen, Nazar Kuzo, Katharina Endres, Christoph Hiemke, Michael Paulzen, Georgios Schoretsanitis
Assessing Pharmacokinetic Correlates of Escitalopram-Related Adverse Drug Reactions. Therapeutic drug monitoring 46 (2) (2024)

volume 46, number 3, 2024

Thuy N T Lien, Sherin M M Mohamed, Bas van den Bogaard, Daan J Touw, Eric J F Franssen
Effects of Plasmapheresis on Serum Lithium Levels in an ICU Patient with Bipolar Disorder: A Case Study. Therapeutic drug monitoring 46 (3) (2024)
Femke Hooijberg, Zohra Layegh, Maureen Leeuw, Laura Boekel, Stefan P H van den Berg, Jill Ruwaard, Carla Bastida, Alwin D R Huitema, Sara Pel, Ori Elkayam, Annick de Vries, Mike Nurmohamed, Theo Rispens, Thomas P C Dorlo, Gertjan Wolbink
Tocilizumab Dose Tapering Based on a Model-Based Algorithm is Feasible in Clinical Practice: A Short Communication. Therapeutic drug monitoring 46 (3) (2024)
Oscar Izarn, Marie-Pascale Morin, Beni Ntobe-Bunkete, Léonard Golbin, Marie-José Ferrand-Sorre, Camille Tron, Florian Lemaitre
Follow the Area Under the Curve Not the Trough Concentration: A Case Study of Tacrolimus Monitoring in a Kidney Transplant Recipient Cotreated With Phenobarbital. Therapeutic drug monitoring 46 (3) (2024)
Marlotte A A van der Veer, Timo R de Haan, Linda G W Franken, Floris Groenendaal, Peter H Dijk, Willem P de Boode, Sinno Simons, Koen P Dijkman, Henrica L M van Straaten, Monique Rijken, Filip Cools, Debbie H G M Nuytemans, Anton H van Kaam, Yuma A Bijleveld, Ron A A Mathôt, null null
Predictive Performance of a Gentamicin Pharmacokinetic Model in Term Neonates with Perinatal Asphyxia Undergoing Controlled Therapeutic Hypothermia. Therapeutic drug monitoring 46 (3) (2024)
Dario Cattaneo, Beatrice Caloni, Stefania Caronni, Nunziata Calvagna, Igor Bonini, Andrea Giacomelli, Cristina Gervasoni
Effect of Carbamazepine on Darunavir Trough Concentrations: When the Dose Can Make the Difference-A Case Study. Therapeutic drug monitoring 46 (3) (2024)
Miroslav Turjap, Marta Pelcová, Jana Gregorová, Pavel Šmak, Hiroko Martin, Jan Štingl, Ondřej Peš, Jan Juřica
Therapeutic Drug Monitoring of Pazopanib in Renal Cell Carcinoma and Soft Tissue Sarcoma: A Systematic Review. Therapeutic drug monitoring 46 (3) (2024)
Nils Tore Vethe, Anders Mikal Andersen, Tobias Gedde-Dahl, Jochen Büchner, Stein Bergan
Therapeutic Drug Monitoring of Intravenous Busulfan and Analytical Challenges due to the Drug Formulation Excipient PEG 400: Letter to the Editor. Therapeutic drug monitoring 46 (3) (2024)
Saeko Kohara, Yoshito Kamijo, Ryoko Kyan, Tsuyoshi Hishikawa, Ichiro Okada, Eiju Hasegawa
Unveiling the Rare Presentation of Acetylsalicylate Overdose: Grand Round. Therapeutic drug monitoring 46 (3) (2024)
Abdul Wasay Sherazi, Ammara Zamir, Anees Ur Rehman, Waseem Ashraf, Imran Imran, Hamid Saeed, Abdul Majeed, Zikria Saleem, Majid Aziz, Faleh Alqahtani, Muhammad Fawad Rasool
A Systematic Critical Review of Clinical Pharmacokinetics of Torasemide. Therapeutic drug monitoring 46 (3) (2024)
Dario Cattaneo, Beatrice Caloni, Stefania Caronni, Nunziata Calvagna, Igor Bonini, Andrea Giacomelli, Cristina Gervasoni
Effect of Carbamazepine on Darunavir Trough Concentrations: When the Dose Can Make the Difference-A Case Study. Therapeutic drug monitoring 46 (3) (2024)
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring 46 (3) (2024)
Miroslav Turjap, Marta Pelcová, Jana Gregorová, Pavel Šmak, Hiroko Martin, Jan Štingl, Ondřej Peš, Jan Juřica
Therapeutic Drug Monitoring of Pazopanib in Renal Cell Carcinoma and Soft Tissue Sarcoma: A Systematic Review. Therapeutic drug monitoring 46 (3) (2024)
Saeko Kohara, Yoshito Kamijo, Ryoko Kyan, Tsuyoshi Hishikawa, Ichiro Okada, Eiju Hasegawa
Unveiling the Rare Presentation of Acetylsalicylate Overdose: Grand Round. Therapeutic drug monitoring 46 (3) (2024)
Femke Hooijberg, Zohra Layegh, Maureen Leeuw, Laura Boekel, Stefan P H van den Berg, Jill Ruwaard, Carla Bastida, Alwin D R Huitema, Sara Pel, Ori Elkayam, Annick de Vries, Mike Nurmohamed, Theo Rispens, Thomas P C Dorlo, Gertjan Wolbink
Tocilizumab Dose Tapering Based on a Model-Based Algorithm is Feasible in Clinical Practice: A Short Communication. Therapeutic drug monitoring 46 (3) (2024)
Oscar Izarn, Marie-Pascale Morin, Beni Ntobe-Bunkete, Léonard Golbin, Marie-José Ferrand-Sorre, Camille Tron, Florian Lemaitre
Follow the Area Under the Curve Not the Trough Concentration: A Case Study of Tacrolimus Monitoring in a Kidney Transplant Recipient Cotreated With Phenobarbital. Therapeutic drug monitoring 46 (3) (2024)
Thuy N T Lien, Sherin M M Mohamed, Bas van den Bogaard, Daan J Touw, Eric J F Franssen
Effects of Plasmapheresis on Serum Lithium Levels in an ICU Patient with Bipolar Disorder: A Case Study. Therapeutic drug monitoring 46 (3) (2024)
Simona De Gregori, Mara Capone, Annalisa De Silvestri, Riccardo Albertini
PEG 400 Ion Suppression in Busulfan Detection by High-Performance Liquid Chromatography-Tandem Mass Spectrometry. Therapeutic drug monitoring 46 (3) (2024)
Abdul Wasay Sherazi, Ammara Zamir, Anees Ur Rehman, Waseem Ashraf, Imran Imran, Hamid Saeed, Abdul Majeed, Zikria Saleem, Majid Aziz, Faleh Alqahtani, Muhammad Fawad Rasool
A Systematic Critical Review of Clinical Pharmacokinetics of Torasemide. Therapeutic drug monitoring 46 (3) (2024)
Bharat Venkatesh, Alex Yuile, Matthew J McKay, Sathya Narayanan, Helen Wheeler, Malinda Itchins, Nick Pavlakis, Stephen J Clarke, Mark P Molloy
A Validated Assay to Quantify Osimertinib and Its Metabolites, AZ5104 and AZ7550, from Microsampled Dried Blood Spots and Plasma. Therapeutic drug monitoring 46 (3) (2024)
Mingfeng Liu, Teng Guo, Zhixue Ma, Liying Du, Juan Hou, Yuan Tian, Meng Meng, Xinran Chen
Correlation Between N-Demethyl Imatinib Trough Concentration and Serious Adverse Reactions in Patients with Gastrointestinal Stromal Tumors: A Retrospective Cohort Study. Therapeutic drug monitoring 46 (3) (2024)
Jane E Carland, Jana Stojanova, Cindy Lau, Richard Osborne Day, Deborah J E Marriott
Crying Over Stark Differences: Resource Disparity and Therapeutic Drug Monitoring. Therapeutic drug monitoring 46 (3) (2024)
Marlotte A A van der Veer, Timo R de Haan, Linda G W Franken, Floris Groenendaal, Peter H Dijk, Willem P de Boode, Sinno Simons, Koen P Dijkman, Henrica L M van Straaten, Monique Rijken, Filip Cools, Debbie H G M Nuytemans, Anton H van Kaam, Yuma A Bijleveld, Ron A A Mathôt, null null
Predictive Performance of a Gentamicin Pharmacokinetic Model in Term Neonates with Perinatal Asphyxia Undergoing Controlled Therapeutic Hypothermia. Therapeutic drug monitoring 46 (3) (2024)
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring 46 (3) (2024)
Anuj K Bhatnagar, Agibothu Kupparam Hemanthkumar, Mariappan Muthu Vijayalakshmi, Vikram Vohra, Padmapriyadarsini Chandrasekaran, Paranchi Murugesan Ramesh, Gaurav Taneja, Vijay Nathu Chavan, Bharathi Jeyadeepa, Namrata Kaur Bhui, Rajesh Solanki
Effect of Bedaquiline and Delamanid Pharmacokinetics on Sputum Culture Conversion and Adverse Events in Drug-Resistant Tuberculosis. Therapeutic drug monitoring 46 (3) (2024)

volume 46, number 4, 2024

Bianca Posocco, Martina Zanchetta, Marco Orleni, Sara Gagno, Marcella Montico, Elena Peruzzi, Rossana Roncato, Lorenzo Gerratana, Serena Corsetti, Fabio Puglisi, Giuseppe Toffoli
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method. Therapeutic drug monitoring 46 (4) (2024)
Marinda Meertens, Niels de Vries, Hilde Rosing, Neeltje Steeghs, Jos H Beijnen, Alwin D R Huitema
Analytical Validation of a Volumetric Absorptive Microsampling Method for Therapeutic Drug Monitoring of the Oral Targeted Anticancer Agents, Abiraterone, Alectinib, Cabozantinib, Imatinib, Olaparib, and Sunitinib, and Metabolites. Therapeutic drug monitoring 46 (4) (2024)
Eun Sil Kim, Hyangah Chon, Yiyoung Kwon, Misook Lee, Mi Jin Kim, Yon Ho Choe
Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation. Therapeutic drug monitoring 46 (4) (2024)
Eun Sil Kim, Hyangah Chon, Yiyoung Kwon, Misook Lee, Mi Jin Kim, Yon Ho Choe
Fluorescence-Based Lateral Flow Immunoassay for Quantification of Infliximab: Analytical and Clinical Performance Evaluation. Therapeutic drug monitoring 46 (4) (2024)
Antonin Dufraigne, Sophie Perinel-Ragey, Jérôme Guitton, Sabine Cohen, Guillaume Thiery, Manon Launay
Monitoring of Tissue and Plasma Imipenem Concentrations for the Treatment of Necrotizing Fasciitis With Carbapenem-Resistant Enterobacteriaceae-A Letter to the Editor. Therapeutic drug monitoring 46 (4) (2024)
Wei Ren, Yingying Fang, Yujing He, Yifeng Ren, Minfang Wang, Anyi Xu, Jiale Ruan, Qinghua Tao
Efficacy and Safety of Programmed Death 1/Programmed Death-Ligand 1 Plus Cytotoxic T-Lymphocyte-Associated Antigen 4 Inhibitors for Advanced or Metastatic Non-Small Cell Lung Cancer: A Meta-analysis Based on Randomized Controlled Trials. Therapeutic drug monitoring 46 (4) (2024)
Melina Vieiros, Afrouz Mirahi, Marina Villarreal, Anna Ramos-Triguero, Iria Fernández-Rubal, Vicente Andreu-Fernández, Simona Pichini, Óscar García-Algar, Emilia Marchei
Prevalence of Psychoactive Substance Use During Pregnancy in Argentine Women: A Pilot Study Testing Maternal Hair. Therapeutic drug monitoring 46 (4) (2024)
Maria Eduarda Soares, Gabriela Costa, Laura Guerra, Maria Clara Morais, Nayana Vaz, Liana Codes, Paulo Lisboa Bittencourt
Influence of Tacrolimus Intrapatient Variability on Allograft Rejection Frequency and Survival Following Liver Transplantation. Therapeutic drug monitoring 46 (4) (2024)
François Parant, Marie-Charlotte Delignette, Bruno Charpiat, Louis Lacaille, Fanny Lebosse, Guillaume Monneret, Kayvan Mohkam, Jean-Yves Mabrut, Frederic Aubrun, Laurent Heyer, Teresa Antonini
Tacrolimus Monitoring in Liver Transplant Recipients, Posttransplant Cholestasis: A Comparative Between 2 Commercial Immunoassays and a Liquid Chromatography-Tandem Mass Spectrometry Method. Therapeutic drug monitoring 46 (4) (2024)
Jessica Gadsby, Lucy Stachow, Hussain Mulla
Age-Related Changes in Vancomycin Protein Binding: Is It Time to Take It Seriously? Therapeutic drug monitoring 46 (4) (2024)
Bingsuo Ma, Kun Yang, Xinping Li, Ning Su, Ting Yu, Yan Zou, Xingmeng Xu, Fei Wang, Jingdong Cheng, Zijun Yan, Tong Chen, Liangming Zhang
Factors Influencing Plasma Concentrations of Valproic Acid in Pediatric Patients With Epilepsy and the Clinical Significance of CYP2C9 Genotypes in Personalized Valproic Acid Therapy. Therapeutic drug monitoring 46 (4) (2024)
Tanja R Zijp, Zamrotul Izzah, Daan J Touw, Job F M van Boven
Medication Adherence Monitoring Using Alternative Sample Matrices: Bridging the Gap Between Analytical Validation and Clinical Interpretation. Therapeutic drug monitoring 46 (4) (2024)
Madeleine Pettersson Bergstrand, Sandra Soeria-Atmadja, Victoria Barclay, Jelena Tolic, Lars Navér, Lars L Gustafsson, Anton Pohanka
Quantification of Efavirenz Hydroxymetabolites in Human Plasma Using LC-HRMS/MS. Therapeutic drug monitoring 46 (4) (2024)
Simona De Gregori, Elena Seminari, Mara Capone, Paola Giordani, Raffaele Bruno, Annalisa De Silvestri
Daptomycin Exposure Prediction With a Limited Sampling Strategy. Therapeutic drug monitoring 46 (4) (2024)
Yoshiaki Yamamoto, Naoto Akita, Hiroki Nogimoto, Wakana Suzuki, Katsumi Imai, Yukitoshi Takahashi, Yoshiyuki Kagawa
Changes in Perampanel Pharmacokinetics and Cytochrome P450 3A4 Activity Before, During, and After Pregnancy. Therapeutic drug monitoring 46 (4) (2024)
Ranita Kirubakaran, Rani M Singh, Jane E Carland, Richard Osborne Day, Sophie L Stocker
Evaluation of Published Population Pharmacokinetic Models to Inform Tacrolimus Therapy in Adult Lung Transplant Recipients. Therapeutic drug monitoring 46 (4) (2024)
Yoshiaki Yamamoto, Naoto Akita, Hiroki Nogimoto, Wakana Suzuki, Katsumi Imai, Yukitoshi Takahashi, Yoshiyuki Kagawa
Changes in Perampanel Pharmacokinetics and Cytochrome P450 3A4 Activity Before, During, and After Pregnancy. Therapeutic drug monitoring 46 (4) (2024)
Xudong Fan, Suhang Guo, Ruoying Zhang, Qingshan Cai, Yazhen Lang, Jinpeng Huang, Yuanyuan Chen, Ying Zhang, Yingying Xu, Meng Chen, Gaoyi Yang, Xinjun Cai
Development, Validation, and Clinical Application of an Ultra-High-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry Method for the Determination of 10 Antituberculosis Drugs in Human Serum. Therapeutic drug monitoring 46 (4) (2024)
Wei Ren, Yingying Fang, Yujing He, Yifeng Ren, Minfang Wang, Anyi Xu, Jiale Ruan, Qinghua Tao
Efficacy and Safety of Programmed Death 1/Programmed Death-Ligand 1 Plus Cytotoxic T-Lymphocyte-Associated Antigen 4 Inhibitors for Advanced or Metastatic Non-Small Cell Lung Cancer: A Meta-analysis Based on Randomized Controlled Trials. Therapeutic drug monitoring 46 (4) (2024)
Dario Cattaneo, Andrea Giacomelli, Nunziata Calvagna, Igor Bonini, Anna Lisa Ridolfo, Cristina Gervasoni
Management of the Drug-Drug Interactions Between Valproic Acid and Dolutegravir-A Case Study. Therapeutic drug monitoring 46 (4) (2024)
Thomas G van Gelder, Valentijn A Schweitzer, Esther V Uijtendaal, Maaike A Sikma
Catching the Culprit: Benzylpenicillin Neurotoxicity Confirmed by Therapeutic Drug Monitoring in a Critically Ill Patient With Continuous Venovenous Hemofiltration. Therapeutic drug monitoring 46 (4) (2024)
Mo'tasem M Alsmadi
Salivary Therapeutic Monitoring of Buprenorphine in Neonates After Maternal Sublingual Dosing Guided by Physiologically Based Pharmacokinetic Modeling. Therapeutic drug monitoring 46 (4) (2024)
Pauline Griffeuille, Souleiman El Balkhi, Sylvain Dulaurent, Franck Saint-Marcoux
Probe Electrospray Ionization Tandem Mass Spectrometry for the Detection and Quantification of Benzodiazepines. Therapeutic drug monitoring 46 (4) (2024)